» Articles » PMID: 24853773

C-reactive Protein and Lung Diseases

Overview
Publisher Elsevier
Date 2014 May 24
PMID 24853773
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

C-reactive protein (CRP), a member of the pentraxin family of plasma proteins, is one of the most distinctive acute phase reactants. In response to inflammation, cell damage or tissue injury, plasma level of CRP rapidly and dramatically increases up to 1000-fold, a phenomenon that has been used for years to monitor infections and many destructive/inflammatory conditions. The magnitude of CRP increase usually correlates with the severity of injury or inflammation and reflects an important physiological role of this interesting but still under-investigated protein. It is now generally accepted that CRP is involved in host defense and inflammation. However, the exact function of this protein in health and disease remains unclear. Many studies have demonstrated that in different pathophysiological conditions CRP might be involved in the regulation of lung function and may participate in the pathogenesis of various pulmonary disorders. The fluctuation of CRP concentrations in both alveolar fluid and serum associated with different pulmonary diseases suggests its important role in lung biology. Discussion of the still controversial functions of CRP in lung physiology and diseases is the main focus of this review.

Citing Articles

Association between C-reactive protein to albumin ratio and chronic obstructive pulmonary disease: a cross-sectional study.

Ao T, Huang Y, Zhen P, Hu M BMC Pulm Med. 2025; 25(1):1.

PMID: 39748377 PMC: 11697920. DOI: 10.1186/s12890-024-03469-w.


Genetic correlation and causal associations between circulating C-reactive protein levels and lung cancer risk.

Shi J, Wen W, Long J, Xue H, Yang Y, Tao R Cancer Causes Control. 2024; 35(6):897-906.

PMID: 38332239 DOI: 10.1007/s10552-024-01855-7.


Evaluation of the effect of Remdesivir on some biomarkers in Iraqi patients with coronavirus 2019 (COVID-19): A cross-sectional study.

Khaleq M J Med Life. 2023; 16(8):1231-1234.

PMID: 38024833 PMC: 10652683. DOI: 10.25122/jml-2023-0209.


p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics.

Ahmadi A, Ahrari S, Salimian J, Salehi Z, Karimi M, Emamvirdizadeh A Cell Commun Signal. 2023; 21(1):314.

PMID: 37919729 PMC: 10623820. DOI: 10.1186/s12964-023-01337-4.


C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians.

Mouliou D Diseases. 2023; 11(4).

PMID: 37873776 PMC: 10594506. DOI: 10.3390/diseases11040132.